Latest & greatest articles for statin

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on statin or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on statin and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for statin

81. Statin-Associated Autoimmune Myopathy.

Statin-Associated Autoimmune Myopathy. Statin-Associated Autoimmune Myopathy. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26886523 Format MeSH and Other Data E-mail Subject Additional text E-mail Add (...) to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2016 Feb 18;374(7):664-9. doi: 10.1056/NEJMra1515161. Statin-Associated Autoimmune Myopathy. . PMID: 26886523 DOI: [Indexed for MEDLINE] Publication type MeSH terms Substances Full Text Sources Medical Miscellaneous PubMed Commons 0 comments How to cite this comment: Supplemental Content Full text links You are here: > > PubMed Simple NCBI Directory Getting

NEJM2016

82. Risk of Congenital Malformations With Statin Therapy During the First Trimester of Pregnancy

Risk of Congenital Malformations With Statin Therapy During the First Trimester of Pregnancy "Risk of Congenital Malformations With Statin Therapy During the First " by Alexander E. Hoffman < > > > > > Title Author Date of Award Summer 8-13-2016 Degree Type Capstone Project Degree Name Master of Science in Physician Assistant Studies First Advisor Brent Norris, PA-C, MS Second Advisor Annjanette Sommers, PA-C, MS Rights . Abstract Background Statins are the most common and effective drug used (...) to treat hyperlipidemia. Based on animal studies showing potential teratogenic effects at high doses, statins are contraindicated in pregnancy due to concern that they would disrupt cholesterol biosynthesis for the fetus. This review evaluates the current evidence of harm caused by statins when taken within the first trimester of pregnancy. Methods An exhaustive literature search was conducted in June 2015 using MEDLINE-Ovid, CINAHL, Evidence-Based Medicine Reviews Multifile, and Web of Sciences

Pacific University EBM Capstone Project2016

83. Among Adult Cancer Survivors Treated With Anthracycline Chemotherapies, Concurrent Statin Therapy May Reduce Their Decline in Left Ventricular Dysfunction

Among Adult Cancer Survivors Treated With Anthracycline Chemotherapies, Concurrent Statin Therapy May Reduce Their Decline in Left Ventricular Dysfunction "Among Adult Cancer Survivors Treated With Anthracycline Chemotherapies" by Mariah McGaffey < > > > > > Title Author Date of Award Spring 8-13-2016 Degree Type Capstone Project Degree Name Master of Science in Physician Assistant Studies First Advisor Annjanette Sommers Rights . Abstract Background: Anthracycline chemotherapies are used (...) to treat a wide variety of malignancies. A study by Von Hoff et al showed that 2.2% of patients previously treated with anthracycline chemotherapy were later diagnosed with heart failure. A more recent study by Smain, et al, showed that 26% of patients receiving higher doses of anthracycline were later diagnosed with heart failure. Statins have been shown to have properties that may allow them to be cardioprotective. Animal research performed by Henninger et al suggests that statin therapy is

Pacific University EBM Capstone Project2016

84. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication

Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication Final Update Summary: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication - US Preventive Services Task Force Search USPSTF Website Text size: Assembly version: 1.0.0.308 Last Build: 3/6/2018 4:20:40 PM You are here: Final Summary Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication Release Date: November 2016 (...) Recommendation Summary Population Recommendation Grade Adults aged 40 to 75 years with no history of CVD, 1 or more CVD risk factors, and a calculated 10-year CVD event risk of 10% or greater The USPSTF recommends that adults without a history of cardiovascular disease (CVD) (ie, symptomatic coronary artery disease or ischemic stroke) use a low- to moderate-dose statin for the prevention of CVD events and mortality when all of the following criteria are met: 1) they are aged 40 to 75 years; 2) they have 1

U.S. Preventive Services Task Force2016

85. Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association

Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association | Circulation Search for this keyword Search Search (...) for this keyword Search Header Publisher Menu AHA Scientific Statement Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association Barbara S. Wiggins , Joseph J. Saseen , Robert L. Page , Brent N. Reed , Kevin Sneed , John B. Kostis , David Lanfear , Salim Virani , Pamela B. Morris and On behalf of the American Heart Association Clinical Pharmacology

American Heart Association2016

86. Usefulness of Nutraceuticals (Armolipid Plus) Versus Ezetimibe and Combination in Statin-Intolerant Patients With Dyslipidemia With Coronary Heart Disease

Usefulness of Nutraceuticals (Armolipid Plus) Versus Ezetimibe and Combination in Statin-Intolerant Patients With Dyslipidemia With Coronary Heart Disease 26611120 2015 11 27 2016 03 15 2015 11 27 1879-1913 116 12 2015 Dec 15 The American journal of cardiology Am. J. Cardiol. Usefulness of Nutraceuticals (Armolipid Plus) Versus Ezetimibe and Combination in Statin-Intolerant Patients With Dyslipidemia With Coronary Heart Disease. 1798-801 10.1016/j.amjcard.2015.09.023 S0002-9149(15)02002-0 (...) Statins are extensively used to treat dyslipidemia, but, because of their low tolerability profile, they are discontinued in a significant proportion of patients. Ezetimibe and nutraceuticals have been introduced as alternative therapies and have proved to be effective and well tolerated. A single-blind, single-center, randomized, prospective, and parallel group trial comparing a combination of nutraceuticals (red yeast rice, policosanol, berberine, folic acid, coenzyme Q10 and astaxanthin), called

EvidenceUpdates2015

87. A Phase 3 Study of Evolocumab (AMG 145) in Statin-Treated Japanese Patients at High Cardiovascular Risk

A Phase 3 Study of Evolocumab (AMG 145) in Statin-Treated Japanese Patients at High Cardiovascular Risk 26547291 2015 12 24 2016 04 26 2015 12 24 1879-1913 117 1 2016 Jan 01 The American journal of cardiology Am. J. Cardiol. A Phase 3 Study of Evolocumab (AMG 145) in Statin-Treated Japanese Patients at High Cardiovascular Risk. 40-7 10.1016/j.amjcard.2015.10.021 S0002-9149(15)02100-1 Evolocumab (AMG 145), a fully human monoclonal antibody against PCSK9, significantly reduced (...) ) calculated LDL-C was 128 (23) mg/dL; after stabilization on atorvastatin 5 and 20 mg/day, baseline LDL-C levels were 118 (35) and 94 (24) mg/dL, respectively. Mean LDL-C reductions at week 12 for evolocumab versus placebo ranged from 67% to 76%. No imbalances were observed in adverse events between treatment groups. Efficacy and safety for Q2W or QM evolocumab dosing were similar. In conclusion, in high-risk Japanese patients receiving stable statin therapy, evolocumab markedly reduced LDL-C and was well

EvidenceUpdates2015

88. Intravenous Immune Globulin for Statin-Triggered Autoimmune Myopathy.

Intravenous Immune Globulin for Statin-Triggered Autoimmune Myopathy. Intravenous Immune Globulin for Statin-Triggered Autoimmune Myopathy. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26488714 Format MeSH (...) and Other Data E-mail Subject Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Oct 22;373(17):1680-2. doi: 10.1056/NEJMc1506163. Intravenous Immune Globulin for Statin-Triggered Autoimmune Myopathy. 1 , . 1 National Institutes of Health, Bethesda, MD andrew.mammen@nih.gov. PMID: 26488714 PMCID: DOI: [Indexed for MEDLINE] Publication types MeSH terms Substances Grant

NEJM2015

89. Ezetimibe plus a Statin after Acute Coronary Syndromes.

Ezetimibe plus a Statin after Acute Coronary Syndromes. Ezetimibe plus a Statin after Acute Coronary Syndromes. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26444739 Format MeSH and Other Data E-mail Subject (...) Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Oct 8;373(15):1475. doi: 10.1056/NEJMc1509363#SA5. Ezetimibe plus a Statin after Acute Coronary Syndromes. . Comment in [N Engl J Med. 2015] Comment on [N Engl J Med. 2015] PMID: 26444739 DOI: [Indexed for MEDLINE] Publication types MeSH terms Substances Full Text Sources Medical Miscellaneous PubMed Commons 0 comments How

NEJM2015 Full Text: Link to full Text with Trip Pro

90. Ezetimibe plus a Statin after Acute Coronary Syndromes.

Ezetimibe plus a Statin after Acute Coronary Syndromes. Ezetimibe plus a Statin after Acute Coronary Syndromes. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26444740 Format MeSH and Other Data E-mail Subject (...) Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Oct 8;373(15):1475-6. doi: 10.1056/NEJMc1509363#SA6. Ezetimibe plus a Statin after Acute Coronary Syndromes. , , . Comment in [N Engl J Med. 2015] Comment on [N Engl J Med. 2015] PMID: 26444740 DOI: [Indexed for MEDLINE] Publication types MeSH terms Substances Full Text Sources Medical Miscellaneous PubMed Commons 0 comments

NEJM2015 Full Text: Link to full Text with Trip Pro

91. Ezetimibe plus a Statin after Acute Coronary Syndromes.

Ezetimibe plus a Statin after Acute Coronary Syndromes. Ezetimibe plus a Statin after Acute Coronary Syndromes. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26444741 Format MeSH and Other Data E-mail Subject (...) Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Oct 8;373(15):1476. doi: 10.1056/NEJMc1509363#SA7. Ezetimibe plus a Statin after Acute Coronary Syndromes. , , . Comment in [N Engl J Med. 2015] Comment on [N Engl J Med. 2015] PMID: 26444741 DOI: [Indexed for MEDLINE] Publication types MeSH terms Substances Full Text Sources Medical Miscellaneous PubMed Commons 0 comments

NEJM2015 Full Text: Link to full Text with Trip Pro

92. Ezetimibe plus a Statin after Acute Coronary Syndromes.

Ezetimibe plus a Statin after Acute Coronary Syndromes. Ezetimibe plus a Statin after Acute Coronary Syndromes. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26444734 Format MeSH and Other Data E-mail Subject (...) Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Oct 8;373(15):1476-7. doi: 10.1056/NEJMc1509363. Ezetimibe plus a Statin after Acute Coronary Syndromes. , , . Comment on [N Engl J Med. 2015] [N Engl J Med. 2015] [N Engl J Med. 2015] [N Engl J Med. 2015] [N Engl J Med. 2015] [N Engl J Med. 2015] [N Engl J Med. 2015] [N Engl J Med. 2015] PMID: 26444734 DOI: [Indexed

NEJM2015

93. Ezetimibe plus a Statin after Acute Coronary Syndromes.

Ezetimibe plus a Statin after Acute Coronary Syndromes. Ezetimibe plus a Statin after Acute Coronary Syndromes. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26444735 Format MeSH and Other Data E-mail Subject (...) Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Oct 8;373(15):1473. doi: 10.1056/NEJMc1509363#SA1. Ezetimibe plus a Statin after Acute Coronary Syndromes. , , . Comment in [N Engl J Med. 2015] Comment on [N Engl J Med. 2015] PMID: 26444735 DOI: [Indexed for MEDLINE] Publication types MeSH terms Substances Full Text Sources Medical Miscellaneous PubMed Commons 0 comments

NEJM2015 Full Text: Link to full Text with Trip Pro

94. Ezetimibe plus a Statin after Acute Coronary Syndromes.

Ezetimibe plus a Statin after Acute Coronary Syndromes. Ezetimibe plus a Statin after Acute Coronary Syndromes. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26444736 Format MeSH and Other Data E-mail Subject (...) Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Oct 8;373(15):1473-4. doi: 10.1056/NEJMc1509363#SA2. Ezetimibe plus a Statin after Acute Coronary Syndromes. , , . Comment in [N Engl J Med. 2015] Comment on [N Engl J Med. 2015] PMID: 26444736 DOI: [Indexed for MEDLINE] Publication types MeSH terms Substances Full Text Sources Medical Miscellaneous PubMed Commons 0 comments

NEJM2015 Full Text: Link to full Text with Trip Pro

95. Ezetimibe plus a Statin after Acute Coronary Syndromes.

Ezetimibe plus a Statin after Acute Coronary Syndromes. Ezetimibe plus a Statin after Acute Coronary Syndromes. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26444737 Format MeSH and Other Data E-mail Subject (...) Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Oct 8;373(15):1474. doi: 10.1056/NEJMc1509363#SA3. Ezetimibe plus a Statin after Acute Coronary Syndromes. . Comment in [N Engl J Med. 2015] Comment on [N Engl J Med. 2015] PMID: 26444737 DOI: [Indexed for MEDLINE] Publication types MeSH terms Substances Full Text Sources Medical Miscellaneous PubMed Commons 0 comments How

NEJM2015 Full Text: Link to full Text with Trip Pro

96. Ezetimibe plus a Statin after Acute Coronary Syndromes.

Ezetimibe plus a Statin after Acute Coronary Syndromes. Ezetimibe plus a Statin after Acute Coronary Syndromes. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26444738 Format MeSH and Other Data E-mail Subject (...) Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Oct 8;373(15):1474-5. doi: 10.1056/NEJMc1509363#SA4. Ezetimibe plus a Statin after Acute Coronary Syndromes. , . Comment in [N Engl J Med. 2015] Comment on [N Engl J Med. 2015] PMID: 26444738 DOI: [Indexed for MEDLINE] Publication types MeSH terms Substances Full Text Sources Medical Miscellaneous PubMed Commons 0 comments

NEJM2015 Full Text: Link to full Text with Trip Pro

97. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines

Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines 26224808 2015 09 10 2015 12 04 2016 12 03 1524-4539 132 10 2015 Sep 08 Circulation Circulation Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines. 916-22 10.1161/CIRCULATIONAHA (...) .115.016846 In the general population, the majority of cardiovascular events occur in people at the low to moderate end of population risk distribution. The 2013 American College of Cardiology/American Heart Association guideline on the treatment of blood cholesterol recommends consideration of statin therapy for adults with an estimated 10-year atherosclerotic cardiovascular disease (ASCVD) risk ≥7.5% based on traditional risk factors. Whether use of nontraditional risk markers can improve risk

EvidenceUpdates2015

98. Do statins increase the risk of developing diabetes?

Do statins increase the risk of developing diabetes? Do statins increase the risk of developing diabetes? Toggle navigation Shared more. Cited more. Safe forever. Toggle navigation View Item JavaScript is disabled for your browser. Some features of this site may not work without it. Search MOspace This Collection Browse Statistics Do statins increase the risk of developing diabetes? View/ Open Date 2015-04 Contributor Format Metadata Abstract Q: Do statins increase the risk of developing (...) diabetes? A: Yes. Statin therapy produces a small increase in the incidence of diabetes: one additional case per 255 patients taking statins over 4 years (strength of recommendation [SOR]: A, meta-analysis). Intensive statin therapy, compared with moderate therapy, produces an additional 2 cases of diabetes per 1000 patient years (SOR: B, meta-analysis with significant heterogeneity among trials). URI Citation Journal of Family Practice, 64(4) 2015: 245-246. Collections hosted by hosted by

Clinical Inquiries2015

99. Do statins increase the risk of developing diabetes?

Do statins increase the risk of developing diabetes? Do statins increase the risk of developing diabetes? Toggle navigation Shared more. Cited more. Safe forever. Toggle navigation View Item JavaScript is disabled for your browser. Some features of this site may not work without it. Search MOspace This Collection Browse Statistics Do statins increase the risk of developing diabetes? View/ Open Date 2015-04 Contributor Format Metadata Abstract Q: Do statins increase the risk of developing (...) diabetes? A: Yes. Statin therapy produces a small increase in the incidence of diabetes: one additional case per 255 patients taking statins over 4 years (strength of recommendation [SOR]: A, meta-analysis). Intensive statin therapy, compared with moderate therapy, produces an additional 2 cases of diabetes per 1000 patient years (SOR: B, meta-analysis with significant heterogeneity among trials). URI Citation Journal of Family Practice, 64(4) 2015: 245-246. Collections hosted by hosted by

Clinical Inquiries2015

100. Prescribing statins for patients with ACS? No need to wait

Prescribing statins for patients with ACS? No need to wait Prescribing statins for patients with ACS? No need to wait Toggle navigation Shared more. Cited more. Safe forever. Toggle navigation View Item JavaScript is disabled for your browser. Some features of this site may not work without it. Search MOspace This Collection Browse Statistics Prescribing statins for patients with ACS? No need to wait View/ Open Date 2014-12 Format Metadata Abstract PRACTICE CHANGER: Prescribe a high-dose statin

PURLS2015